Overview

Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma

Status:
Terminated

Trial end date:
2019-05-25

Target enrollment:

Participant gender:

Summary

The purpose of this study is to test the safety of the treatment combination of alternating standard chemotherapy and another (melphalan) chemotherapy at different interval schedules. Researchers want to find out what effects, good and/or bad, the treatment combination has on the patients and their retinoblastoma.

Phase:

Phase 1

Details

Lead Sponsor:

University of California, San Francisco

Treatments:

Carboplatin
Etoposide
Melphalan
Vincristine